Stay updated on Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed, indicating a backend version update with no change to the study data presented.
    Difference
    0.1%
    Check dated 2026-01-14T02:16:12.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Locations now include Ohio as a study site; the Ohio Locations entry was removed and the HHS Vulnerability Disclosure footer link was deleted.
    Difference
    0.2%
    Check dated 2025-12-23T10:41:51.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1 on the page; no study content, eligibility criteria, or results are changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T18:28:10.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    - The page shows an updated revision number from v3.2.0 to v3.3.1, with no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:57:11.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Removed the informational funding/operating-status notice that previously appeared at the top; this banner does not modify study details, eligibility criteria, or contact information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:11:07.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page shows minor formatting and layout tweaks with no changes to core content such as eligibility criteria, outcomes, or study arms. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:23:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.